98 related articles for article (PubMed ID: 6380030)
1. The response of Plasmodium vivax to antifols.
Bray RS
Trans R Soc Trop Med Hyg; 1984; 78(3):420-1. PubMed ID: 6380030
[No Abstract] [Full Text] [Related]
2. Studies on the characterization of plasmodium vivax strains from Central America.
Contacos PG; Collins WE; Jeffery GM; Krotoski WA; Howard WA
Am J Trop Med Hyg; 1972 Sep; 21(5):707-12. PubMed ID: 4627547
[No Abstract] [Full Text] [Related]
3. Chemotherapy of the drug-resistant malarias.
Schmidt LH
Annu Rev Microbiol; 1969; 23():427-54. PubMed ID: 4901983
[No Abstract] [Full Text] [Related]
4. [Tolerance of Plasmodium falciparum to pyrimethamine, proguanil and C.I. 501 in the Niayes region (Senegal)].
Michel R; Pene P; Courtney KO
Bull Soc Pathol Exot Filiales; 1966; 59(5):797-803. PubMed ID: 6014281
[No Abstract] [Full Text] [Related]
5. Which prophylactic drugs for malaria?
Copper JR
Br Med J; 1979 Oct; 2(6197):1071-2. PubMed ID: 391331
[No Abstract] [Full Text] [Related]
6. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M
JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the chemotherapy of malaria.
Pinder RM
Prog Med Chem; 1971; 8(2):231-316. PubMed ID: 4947769
[No Abstract] [Full Text] [Related]
8. Studies on the chemotherapy of malaria. II. Pyrimethamine resistance in The Gambia.
Laing AB
Trans R Soc Trop Med Hyg; 1970; 64(4):569-80. PubMed ID: 4922133
[No Abstract] [Full Text] [Related]
9. Gametocytocidal and sporontocidal effects of antimalarial drugs on malaria parasites. II. Action of the folic reductase inhibitors, chlorguanide, and pyrimethamine against Plasmodium cynomolgi.
Omar MS; Collins WE; Contacos PG
Exp Parasitol; 1974 Oct; 36(2):167-77. PubMed ID: 4413531
[No Abstract] [Full Text] [Related]
10. An evaluation of CI-564 against blood-induced chlorguanide-sensitive and chlorguanide-resistant strains of vivax malaria.
Chin W; Coatney GR; King HK
Am J Trop Med Hyg; 1967 Jan; 16(1):13-4. PubMed ID: 5336629
[No Abstract] [Full Text] [Related]
11. The effect of biweekly administration of 50 mg pyrimethamine in prevention of falciparum and vivax malaria.
Yang TH; K'an SN; Yang SA; Chang L; Huang PP
Chin Med J; 1965 Dec; 84(12):809-12. PubMed ID: 5324783
[No Abstract] [Full Text] [Related]
12. Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.
Fogh S; Schapira A; Bygbjerg IC; Jepsen S; Mordhorst CH; Kuijlen K; Ravn P; Rønn A; Gøtzsche PC
Br Med J (Clin Res Ed); 1988 Mar; 296(6625):820-2. PubMed ID: 3130927
[TBL] [Abstract][Full Text] [Related]
13. Drug-resistant malaria.
Lancet; 1969 Jun; 1(7608):1245. PubMed ID: 4182418
[No Abstract] [Full Text] [Related]
14. The suppression of Plasmodium falciparum and Plasmodium vivax parasitaemias by a dapsone-pyrimethamine combination.
Segal HE; Pearlman EJ; Thiemanun W; Castaneda BF; Ames CW
J Trop Med Hyg; 1973 Nov; 76(11):285-90. PubMed ID: 4586093
[No Abstract] [Full Text] [Related]
15. The epidemiology of drug-resistant malaria.
Björkman A; Phillips-Howard PA
Trans R Soc Trop Med Hyg; 1990; 84(2):177-80. PubMed ID: 2202097
[No Abstract] [Full Text] [Related]
16. [The proper use of antimalarial drugs currently available].
Bourgeade A; Delmont J
Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
[TBL] [Abstract][Full Text] [Related]
17. [Drug resistance in malaria].
Wery M; Coosemans M
Ann Soc Belg Med Trop; 1980 Jun; 60(2):137-62. PubMed ID: 7018421
[No Abstract] [Full Text] [Related]
18. Treatment of vivax malaria with sulfadoxine-pyrimethamine and with pyrimethamine alone.
Doberstyn EB; Teerakiartkamjorn C; Andre RG; Phintuyothin P; Noeypatimanondh S
Trans R Soc Trop Med Hyg; 1979; 73(1):15-7. PubMed ID: 375485
[TBL] [Abstract][Full Text] [Related]
19. Malaria. Chemoprophylaxis and chemotherapy.
Peters W
Br Med J; 1971 Apr; 2(5753):95-8. PubMed ID: 4927912
[No Abstract] [Full Text] [Related]
20. Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.
Davis TM
Ann Pharmacother; 1998 Oct; 32(10):1104-6. PubMed ID: 9793605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
